BIOBLAST PHARMA LTD's ticker is and the CUSIP is M20156119. A total of 3 filers reported holding BIOBLAST PHARMA LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 14,103 | $11,000 | 0.00% |
| Renaissance Technologies | 130,128 | $101,000 | 0.00% |
| UBS Group AG | 4,916 | $4,000 | 0.00% |
| FLAGSHIP HARBOR ADVISORS, LLC | 140 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |